![]() |
|
|
Vol. 302, Issue 2, 424-432, August 2002
Department of Pharmacology and Toxicology, Institute of Environmental Toxicology, and Neuroscience Program, Michigan State University, East Lansing, Michigan
| |
Abstract |
|---|
|
|
|---|
Methylmercury (MeHg) disrupts the function of native, high
voltage-activated neuronal Ca2+ channels in several types
of cells. However, the effects of MeHg on isolated Ca2+
channel phenotypes have not been examined. The aim of the present study
was to examine the action of MeHg on recombinant, neuronal L-type
voltage-sensitive Ca2+ channels. Human embryonic kidney
cells (HEK-293) were transfected with human neuronal cDNA clones of the
1C-1 subunit in combination with
2b and
3a Ca2+ channel subunits and the reporter
jellyfish green fluorescent protein for transient expression. Current
from expressed channels (IBa) and their response
to MeHg applied acutely were measured using whole-cell voltage-clamp
recording techniques and Ba2+ (5 mM) as charge carrier.
Amplitude of IBa in these cells was reduced by
the dihydropyridine (DHP), nimodipine, and enhanced by Bay
K8644
[S-(
)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)-3 pyridine carboxylic acid methyl ester]. MeHg
(0.125-5.0 µM) caused a time- and concentration-dependent reduction
in amplitude of the peak and sustained current through these channels.
However, even at the highest concentration of MeHg tested, reduction of current amplitude by MeHg was incomplete. Washing with MeHg-free solution could not reverse its effects. The steady-state inactivation curve was unaltered by MeHg. Increasing the stimulation frequency or
the extracellular Ba2+ concentration each attenuated
slightly the reduction in amplitude of IBa by
MeHg. In the presence of MeHg (5.0 µM), Bay K8644 still increased the
remaining current, and nimodipine (10 µM) reduced residual current
that was resistant to MeHg. Thus, although MeHg reduces the amplitude
of recombinant, heterologously expressed L-type channel current, a
portion of current is resistant to reduction by MeHg. Furthermore, DHP
agonists and antagonists retain their ability to affect L-type
Ca2+ channel current even in the presence of MeHg.
| |
Introduction |
|---|
|
|
|---|
Voltage-sensitive
Ca2+ channels play critical roles in a number of
cellular functions such as synaptic transmission, muscle contraction,
and regulation of gene expression (Catterall, 1998
). Several distinct
subtypes of "high voltage-activated" Ca2+
channels (L, N, P/Q, and R) have been identified based on their biophysical and pharmacological properties (Tsien et al., 1995
). L-type
channels, the subject of the present study, are present in various
forms in both neurons and other kinds of cells.
Ca2+ channels in general are affected by the
actions of a number of toxicants (Kiss and Osipenko, 1994
; Sirois and
Atchison, 1996
). Because of the crucial roles these proteins play in
key cellular functions, toxicant effects on
Ca2+ channels could have significant
deleterious consequences on cell function (Audesirk et al., 2001
).
Methylmercury (MeHg) is an important environmental contaminant
that has been responsible for episodes of mass environmental neurotoxicity in Minamata, Japan (Takeuchi, 1982
) and Iraq (Bakir et
al., 1973
). MeHg neurotoxicity remains a contemporary concern, especially for populations with a high component of fish in their diet
(Kosatsky and Dumont 1991
; Grandjean et al., 1997
; Hansen and Danscher,
1997
; Renzoni et al., 1998
). The mechanisms underlying MeHg
neurotoxicity are unclear, and multiple sites of action probably contribute to the ultimate expression of toxicity (Atchison and Hare,
1994
). Among the many cellular targets associated with effects of MeHg,
voltage-gated Ca2+ channels including,
apparently, the L-type, are affected rapidly and at low micromolar
concentrations in isolated systems.
The actions of MeHg on Ca2+ channels are
conflicting, depending upon the type of measurement being made. Like
divalent heavy metals such as Pb2+,
Cd2+, and inorganic Hg2+,
acute application of MeHg to cells in culture causes a marked reduction
in amplitude of native currents carried through
Ca2+ channels (Shafer and Atchison, 1991
; Sirois
and Atchison, 2000
). Similarly, reduced influx of
45Ca2+ during KCl-induced
depolarization results from extremely brief (1 s) exposures to MeHg in
rat cortical synaptosomes (Atchison et al., 1986
; Shafer and Atchison,
1989
; Shafer et al., 1990
; Hewett and Atchison, 1992
). However, in
functional assays of effects of MeHg on regulation of intracellular
free Ca2+ using measurements of Fura-2
acetoxymethyl ester fluorescence, continuous exposure to MeHg (0.1-5
µM) for periods of up to an hour induces an increase in intracellular
Ca2+, part of which occurs by entry of
Ca2+ from the extracellular medium (Denny et al.,
1993
; Hare et al., 1993
). In both NG108-15 cells and primary cultures
of cerebellar granule cells, nifedipine, a dihydropyridine (DHP)-type
blocker of L-type Ca2+ channels, delays the onset
of this MeHg-mediated influx of extracellular Ca2+ (Hare and Atchison 1995
; Marty and
Atchison 1997
), and partially protects granule cells in culture from
MeHg-induced cytotoxicity (Marty and Atchison, 1998
). Moreover, in vivo
administration of nifedipine and other Ca2+
channel blockers protects rats from MeHg-induced neurotoxicity (Sakamoto et al., 1996
). These observations suggest that at least some
of the effects of MeHg are mediated by L-type
Ca2+ channels or, alternatively, that MeHg, like
Pb2+ (Simons and Pocock, 1987
), may enter neurons
by means of L-type Ca2+ channels.
To begin to reconcile these seemingly contradictory effects of MeHg and
hence understand more clearly the actions of MeHg on voltage-gated
Ca2+ channels, we undertook the first study of
actions of MeHg on a homogeneous population of a single defined
phenotype of Ca2+ channels. One problem with
existing studies using native cell currents is that multiple types of
Ca2+ channels occur in these preparations (Sirois
and Atchison, 2000
), and pharmacological methods for isolating a single
phenotype are incomplete. Thus, theoretically, MeHg could act
differentially on different subtypes of Ca2+
channels, perhaps impeding current flow through one subtype, while not
affecting, or actually facilitating, current flow through another.
Because of the protective effects of L-type Ca2+
channel antagonists against MeHg-induced neurotoxicity in several experimental paradigms, we chose to focus initially on this phenotype in isolation using a heterologous expression system. Specifically, the
goal of the present study was to determine whether current through
L-type voltage-sensitive Ca2+ channels was
reduced by acute administration of MeHg and, if so, what were the
characteristics of reduction of channel function by MeHg.
To do this, we used recombinant clones of human neuronal L-type
Ca2+ channels expressed using cDNA copies of
their genes transferred into human embryonic kidney cells (HEK-293).
These nonexcitable cells are commonly used for heterologous expression
of membrane proteins including voltage-dependent
Ca2+ channels (Williams et al., 1994
;
Perez-Garcia et al., 1995
; Querfurth et al., 1998
). Whole-cell
voltage-clamp methods were used to characterize the currents expressed
in these cells, and then to examine the actions of MeHg on these currents.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Human embryonic kidney cells (HEK-293, ATCC
number CRL-1573) were purchased from the American Type Culture
Collection (Manassas, VA). All reagents were pure or ultra-pure
laboratory grade unless otherwise noted. S-(
)-Bay
K8644, (
)-nimodipine, ATP-Mg, cAMP, HEPES, EGTA, and
tetrodotoxin were obtained from Sigma-Aldrich (St. Louis, MO). Bay
K8644 and nimodipine were made up as stock solutions in absolute
ethanol to give final concentrations in solutions, which limited the
ethanol concentration to less than 0.1% (v/v). Stock solutions (5 mM)
of methylmercuric chloride (MeHg) (ICN Pharmaceuticals, Costa Mesa, CA)
were prepared weekly in double distilled water, from which test
solutions were prepared daily in extracellular solution. Expression
cDNA clone plasmids of the human neuronal Ca2+
channel subunits used in the study were all generously provided by Dr.
Kenneth A. Stauderman of SIBIA Neurosciences (San Diego, CA), now Merck
Research Laboratories.
1C-1 and
3a cDNA were isolated from hippocampus (Mark
Williams, Merck Research, personal communication);
2b was isolated from cerebellum (Williams et al., 1992
).
Cell Culture and Transfection.
HEK-293 cells were grown at
37°C in Eagle's minimal essential medium fortified with 1 mM sodium
pyruvate, 0.1 mM nonessential amino acids, 2 mM
L-glutamine, 1.5 g/l sodium bicarbonate, 10% fetal bovine
serum, and penicillin/streptomycin/amphotericin B (Invitrogen,
Carlsbad, CA) in a 5% CO2 environment. One day
before gene transfer, cells were plated at a density of 5 × 105 on 35-mm culture dishes. Cells were
transfected with a mixture of plasmids containing
1C-1,
2b, and
3a Ca2+ channel subunits
and a jellyfish green fluorescent protein (GFP) cDNA sequence using
Fugene 6 (Roche Applied Science, Indianapolis, IN) following the
manufacturer's instructions. Reactions contained a total of 3 µl of
Fugene 6 and 1 µg of plasmid DNA containing the three subunits in a
1:1:1 molar ratio, with GFP plasmid at 20% of the total DNA. Two days
were allowed for optimal transient expression of proteins, at which
time the cells were examined for GFP expression. Cells from dishes with
a reasonable number of green fluorescent cells (usually 20%) were
replated at a lower density to facilitate recording. Recordings were
typically made using cells from a minimum of three independent transfections.
Ca2+ Channel Current Recording.
Prior to
recording, culture medium was removed, and cells were rinsed twice with
extracellular solution and then replenished with 1 ml of extracellular
recording bath solution. The extracellular solution contained 150 mM
tetraethylammonium chloride, 5 mM BaCl2, 1 mM
MgCl2, 25 mM D-glucose, 10 mM HEPES,
0.001 mM tetrodotoxin, pH adjusted to 7.2 at room temperature
(~23-25°C) with tetraethylammonium hydroxide. The osmolarity of
solution was 310 mOsm. In some experiments, [BaCl2] was increased to 20 mM; the
tetraethylammonium chloride concentration was simultaneously reduced to
117 mM to maintain iso-osmolarity. Patch-clamp pipettes with
resistances between 6 and 8 M
were prepared from 1.5-mm-i.d. glass
capillaries (World Precision Instruments, Sarasota, FL) using a PP-830
two-stage microelectrode puller (Narishige, Tokyo, Japan) and
fire-polished using an MF-830 microforge (Narishige). The intracellular
(pipette) solution contained 140 mM CsCl, 10 mM EGTA, 10 mM HEPES, 2 mM ATP-Mg, and 1 mM cAMP; pH was adjusted to 7.2 at room temperature with CsOH.
3
dB, four-pole Bessel filter; Axon Instruments) and acquired online
using the pClamp6 program (Axon Instruments). Pipette and cell
capacitance were compensated online in all experiments. Series
resistance was also compensated online in the range of 60 to 80%.
Extracellular media were exchanged using a gravity-fed bath perfusion
system (BPS-4; ALA Scientific Instruments, Westbury, NY); the flow rate
was 5 × 10
3 ml/s. The distance of the
flow pipette from the cell remained approximately 150 µm and the
pipette tip diameter was 300 µm. All experiments were carried out at
room temperature (~23-25°C).
Except when noted otherwise, a pulse protocol was used to examine the
effects of MeHg on membrane currents. A hyperpolarizing pulse with
one-quarter of the test pulse magnitude was applied to measure the leak
current, followed by a depolarizing pulse to elicit inward current.
Linear components of leak and capacitive current were not subtracted
online from these records. Thus, effects of MeHg on inward current,
leak current, and capacitive current could be examined in consecutive
current traces. This pulse protocol was repeated once every 10 s.
Leak subtraction was performed offline, subtracting the scaled current
observed with the P/N protocol. For some experiments, a ramp protocol
was used. The duration of the ramp was 150 ms and the interval between
ramps was 30 s.
Statistical Analysis. Origin (MicroCal, Northampton, MA) and pClamp (Axon Instruments) software suites were used to perform linear and nonlinear fit of data. Statistical comparisons were performed using paired Student's t test. Results are expressed as mean ± standard error of the mean, and p < 0.05 was considered to be statistically significant. Asterisks indicate statistically significant differences: *p < 0.05, **p < 0.01, and ***p < 0.001.
| |
Results |
|---|
|
|
|---|
Characteristics of Current Expressed by Recombinant
1C,
2, and
Subunits of
Ca2+ Channels in HEK-293 Cells.
Expression of cloned
Ca2+ channels in HEK-293 cells, using the
above-mentioned protocol, produced IBa with
biophysical and pharmacological similarities to the neuronal L-type
Ca2+ channel expressed in its native environment.
Representative IBa results elicited from
these cells along with their current-voltage relationship are shown in
Fig. 1, A and B. No significant inward current was observed until the depolarizing step reached
40 mV. Currents reached maximum amplitude at approximately 0 mV, and the
reversal potential was approximately +50 mV. The peak current shows
voltage dependence and inactivated only slowly.
|
), of these
Ca2+ channels, where
m
was determined from the relative
amplitudes of currents
(I/Imax) elicited at
different test membrane potentials. The voltage for half-maximal
activation (V1/2) was
18.8 mV. The isochronal inactivation (h
) was
determined using an 8-s inactivating prepulse. The inactivation curve
is shown with slope factor (K) of 13.3 mV and
V1/2 of
53.0 mV.
Figure 2 demonstrates DHP antagonist and
agonist sensitivity of IBa elicited from
these recombinant Ca2+ channels. Application of
the agonist Bay K8644 (10 µM) caused a 100% increase of peak current
(Fig. 2, A and C), whereas addition of the DHP antagonist nimodipine
(10 µM) reduced the current by more than 90% (Fig. 2, B and C).
|
Characteristics of Reduction of IBa by
MeHg.
As shown in representative traces (Fig.
3A), and in composite data from a number
of recordings (Fig. 3B), continuous superfusion with MeHg caused a
time-dependent reduction of IBa in
transfected cells. The degree of reduction of current appeared to be
approximately the same for both peak and sustained components of
current (Fig. 3A). Thus, inactivation did not appear to be affected by
MeHg under these conditions. The time course of effect on
IBa of different concentrations of MeHg
(0.125-5.0 µM) is shown in Fig. 3B. MeHg was applied after at least
5 min of stabilization of the control current. In comparison with
control cells, which underwent 10% rundown of current during 9 min of
continuous recording, MeHg treatment caused an apparent
concentration-dependent reduction in the magnitude of
IBa after leak subtraction. Reduction of
peak current was incomplete and reached a plateau at approximately 80%
reduction with 5.0 µM MeHg. Preliminary experiments indicated that
application of 10 µM MeHg caused no further decrease in current amplitude (results not shown). The reduction in current amplitude by
MeHg appeared to follow two distinct phases: one that was initially rapid, and the other, gradual and progressive. Depending upon the
concentration of MeHg used, the rapid phase was completed between 100 and 150 s after beginning treatment. Lower concentrations of MeHg
(0.125-1.25 µM) caused a more gradual decline in current amplitude.
Figure 4 depicts the inhibition of peak
current by various concentrations of MeHg after a 2-min exposure.
|
|
|
Effect of DHPs on Reduction of IBa by
MeHg.
Current carried through these recombinant
Ca2+ channels expressed in HEK-293 cells was
sensitive to DHP-type drugs. MeHg has been reported to decrease the
affinity of binding for [3H]nitrendipine to
cortical synaptosomes (Shafer et al., 1990
). Thus, we sought to
determine whether MeHg caused its inhibitory effect by acting at sites
that might overlap with those used by DHP-type
Ca2+ channel antagonists or agonists.
Consequently, nimodipine or Bay K8644 was applied in the continued
presence of MeHg. As seen in Fig. 6A, 10 µM nimodipine was able to elicit a further decline in the current
remaining, even after a 5-min exposure to 5 µM MeHg. Furthermore,
after a similar reduction by MeHg, 10 µM Bay K8644 was able to cause
a slight increase in the residual current (Fig. 6B).
|
Voltage Dependence of IBa Reduction by
MeHg.
To determine whether reduction by MeHg of the heterologously
expressed L-type Ca2+ channel-mediated current is
voltage-dependent, we applied a ramp protocol to obtain the
current-voltage relationships for IBa. Inactivation properties were studied by varying the holding potential for 8 s before applying a test pulse to 0 mV in the presence or absence of MeHg. Figure 7A shows the
current-voltage relationships for IBa before and
after addition of 5.0 µM MeHg at different times of exposure. MeHg
decreased the peak current amplitude at all potentials that activated
current, but did not alter either the threshold of activation of
IBa or the reversal potential. There were
slight changes in the potential at which the maximum current was
elicited; for example, there appeared to be a slight shift in the
hyperpolarizing direction at 3 min (Fig. 7A). However, there was no
apparent consistent pattern evident in these changes. MeHg had no
effect on the inactivation curve (Fig. 7B).
|
Frequency Dependence of IBa Reduction by
MeHg.
Some chemicals block ion channels in a use-dependent manner
(Hille, 1992
). During this process, the inhibitory effect is enhanced because of repetitive opening of the channels by increasing the stimulation frequency. The premise is that these inhibitors act either
at sites within the channel or intracellularly. Shafer and Atchison
(1991)
and Sirois and Atchison (2000)
demonstrated that the effect of
MeHg on Ca2+ channels is use-dependent in PC12
and cerebellar granule cells, respectively. We examined whether this
type of reduction could also occur in recombinant
Ca2+ channels by stimulating transfected cells at
frequencies of 0.1, 0.2, and 0.4 Hz. No frequency-dependent enhancement
of MeHg-induced reduction of current amplitude was observed. Instead,
the effect of MeHg on peak currents was either unchanged or actually
reduced at higher stimulation frequencies (0.2 and 0.4 Hz; Fig.
8A), depending upon the duration of
exposure to MeHg. At a stimulation frequency of 0.1 Hz, 5 µM MeHg
reduced peak current by 67 ± 7% and 83 ± 3% after a 4-min
and a 9-min exposure, respectively. When the stimulation frequency was
increased, initially, the rate of decline of current amplitude appeared
identical to that at 0.1 Hz. At both 0.2 and 0.4 Hz, there was a
transient reversal of block by MeHg that occurred at ~150 s. In each
case this reversal lasted for about 75 s and caused an ~33%
increase in current amplitude despite the continued presence of MeHg.
However, by a little over 200 s, current amplitude again began to
decline. Although the rates of decline were not measured
mathematically, visual inspection suggested that the rate of decline
after this transient reversal was approximately equivalent to that
prior to the reversal. At 0.2 Hz, the reduction of peak current induced
by 5 µM MeHg was decreased to 43 ± 6% (p < 0.05) and 69 ± 2% (p < 0.05) after 4-min and
9-min exposures, respectively. At a stimulation frequency of 0.4 Hz, 5 µM MeHg induced an even smaller reduction than it did at 0.1 Hz
during 4 min of exposure (36 ± 1%, p < 0.05).
After a 9-min exposure, the reduction of peak current at 0.4 Hz
(82 ± 3%) was not significantly different from that at 0.1 Hz. A
similar reduction in inhibition was observed with 1.25 µM MeHg. At a
stimulation frequency of 0.1 Hz, peak current amplitude was reduced by
70 ± 6% after 9 min of exposure to MeHg. After the stimulation
frequency was increased to 0.2 Hz, peak current amplitude was reduced
by only 50 ± 3% (Fig. 8B).
|
Increasing [Ba2+]e Reduces the
Effectiveness of Block of IBa by MeHg.
If
the mechanism by which a divalent cation acts involves direct occlusion
of the channel within the pore itself, the effectiveness of reduction
in current would depend on the concentration of charge carrier.
Increasing [Ca2+]e
counters the magnitude of reduction of
45Ca2+ influx in
synaptosomes by MeHg (Atchison et al., 1986
; Shafer and Atchison,
1989
), and increasing the
[Ba2+]e slightly reduces
the negative effect of MeHg on IBa in PC12 cells (Shafer and Atchison, 1991
). As such, we sought to determine whether this action was associated with recombinant L-type
Ca2+ channels. Indeed, the degree to which 5.0 µM MeHg reduced the peak current through these channels was dependent
on the concentration of Ba2+ used. With 5 mM
Ba2+ in the extracellular solution, reduction of
the peak current reached 65 ± 6% after 3 min of exposure to 5.0 µM MeHg. However, with 20 mM Ba2+ as charge
carrier, the reduction of peak current only reached 40 ± 6%
(p < 0.05; Fig. 9). This
suggests that increasing
[Ba2+]e hinders MeHg
action, possibly due to close proximity of binding sites (steric
overlap) or interference between the binding sites (steric hindrance)
for MeHg and Ba2+.
|
| |
Discussion |
|---|
|
|
|---|
The present study is the first to examine the inhibitory actions
of MeHg on a single identified phenotype of voltage-sensitive Ca2+ channels. While corroborating several
aspects of previous studies examining the effects of MeHg on
Ca2+ channel function in native cells, our study
extends them in several important ways. First, MeHg exerts a
concentration-dependent depressant effect on function of neuronal
L-type high voltage-activated Ca2+ channels that
was not readily reversible by washing with MeHg-free solution. Second,
unlike the situation seen for mixed populations of
Ca2+ channels in their native environment,
reduction of current carried through these recombinant L-type
Ca2+ channels by MeHg is not total and apparently
is not mediated by action at the DHP binding site. Third, concentration
of charge carrier can modulate the inhibitory effects of MeHg, due
possibly to steric hindrance or overlap. The overall shape of the
current recordings as well as the voltage and time dependence of the
current recorded from cells transfected with recombinant
Ca2+ channels comprising
1C-1,
2b, and
3a Ca2+ channel subunits
resemble those of native L-type Ca2+ channels.
Furthermore, the IBa from these recombinant
Ca2+ channels exhibits the pharmacological
sensitivities to DHPs in the manner and concentration range reported in
numerous studies on native DHP-sensitive L-type
Ca2+ channels.
MeHg disrupts normal Ca2+ channel function in a
variety of preparations as seen using synaptosome
45Ca2+ influx, ligand
binding, and electrophysiological techniques (Shafer and Atchison,
1989
; Shafer et al., 1990
; Hewett and Atchison, 1992
; Leonhardt et al.,
1996
; Shafer, 1998
). Sirois and Atchison (2000)
demonstrated that MeHg
affects multiple subtypes of Ca2+ channels
including L-type in rat cerebellar granule cells. However, there are no
previous studies on the discrete effects of MeHg on identified subtypes
of Ca2+ channels in isolation, mainly because of
the multiplicity of Ca2+ channel types that
coexist in most primary cultures of neurons, such as cerebellar granule
cells, and the lack of completely specific pharmacological probes. Our
results show that low concentrations of MeHg (0.125-5.0 µM) rapidly
reduced peak IBa in a time- and concentration-dependent manner through recombinant, heterologously expressed L-type Ca2+ channels, a phenotype
expressed in several kinds of neuronal as well as non-neuronal cells.
Currents through recombinant L-type channels were affected at lower
concentrations of MeHg than were ostensibly similar native L-type
currents in rat PC12 cells (Shafer and Atchison, 1991
; Shafer, 1998
)
and dorsal root ganglion cells (Leonhardt et al., 1996
), but the lower
concentration of charge carrier used in our present study as compared
with other studies may have contributed to this effect. Current from
recombinant channels was similar in sensitivity to MeHg to native
currents in rat cerebellar granule cells (Sirois and Atchison, 2000
)
using the same [Ba2+]e.
Other subtle differences are also apparent between our results and
those from native channels. For example, in differentiated PC12 cells,
MeHg (10-20 µM) rapidly and completely blocked whole-cell current
through presumed L-type Ca2+ channels (Shafer and
Atchison, 1991
). In contrast, the recombinant L-type
Ca2+ channel current expressed in HEK-293 cells
could be blocked only incompletely by MeHg. This difference in
pharmacological sensitivity between native and cloned, heterologously
expressed channels has also been reported for calcicludine reduction of
L-type (Stotz et al., 2000
),
-agatoxin IVA reduction of P/Q-type
(Bourinet et al., 1999
), and peptide spider toxin DW13.3 reduction of
N-type (Sutton et al., 1998
) currents. One possible reason for this
apparent difference in our experiments could be the use of a
subunit with properties different from the native
subunits that
associate with the corresponding native L-type
Ca2+ channels;
subunits are known to modulate
channel kinetics (Hofmann et al., 1999
). Different
subunit isoforms
cause shifts in the kinetics and voltage dependence of gating and thus
result in substantially altered
1 subunit
function. In the Xenopus laevis oocyte transfection system,
inactivation and recovery from inactivation of "L-type" channels
depend not only on the nature of the
subunit, but also on the
splice-variant of L-type channel expressed (Soldatov et al., 1997
).
In nerve growth factor-differentiated PC12 cells, which express L-type
Ca2+ channels (Plummer et al., 1989
; Usowicz et
al., 1990
), MeHg appears to reduce current amplitude in a
voltage-dependent manner (Shafer and Atchison, 1991
). In synaptosomes,
reduction of 45Ca2+ influx
induced by MeHg also appears to be voltage-dependent (Shafer et al.,
1990
). However, in rat cerebellar granule cells, which possess multiple
types of Ca2+ channels (L, N, P/Q, and R)
(Randall and Tsien, 1995
), reduction of Ca2+
current amplitudes by 0.25 to 1.0 µM MeHg was not voltage-dependent (Sirois and Atchison, 2000
). In the experiments presented here, the
reduction of peak current by 5.0 µM MeHg occurs at all membrane potentials and does not alter either the threshold of activation of
IBa or the reversal potential. MeHg did
cause some slight changes in the potential at which maximum current is
elicited. However, these effects were not consistent, nor was the
steady-state inactivation curve altered.
If reduction of current amplitude by MeHg occurs through binding within
the pore of the channels or intracellularly, it should exhibit
"use-dependence". In PC12 cells the effect of 5.0 µM MeHg was
facilitated by increasing stimulation frequency from 0.1 to 0.2 or 0.4 Hz (Shafer and Atchison, 1991
). In primary cultures of cerebellar
granule cells, increasing the stimulation rate hastened the onset and
increased the magnitude of reduction at both 0.25 and 0.5 µM MeHg,
but not at 1 µM (Sirois and Atchison, 2000
). In contrast, in our
experiments increasing stimulation does not facilitate the effect of
5.0 µM MeHg and, in fact, decreases it to some extent. It is
difficult to explain definitively the reason for the brief reversal of
MeHg effect (Fig. 8A) at the higher rates of stimulation. We have also
seen a similar phenomenon of temporary reversal under certain
conditions of blocking action of MeHg on
Ca2+-dependent synaptic transmission in isolated
brain slices (Yuan and Atchison, 1993
) and motor end plates (Traxinger
and Atchison, 1987
). Perhaps a subset of Ca2+
channels remains closed during the lower stimulation rate but opens up
during the faster stimulations, causing current flow for a limited time
before the effect of MeHg sets in. As such, there may be a frequency-
and time-dependent "revealing" of additional channels that become
available to conduct current before they too are affected by the MeHg.
Increasing the extracellular concentration of
Ba2+ from 5 mM to 20 mM partially attenuated the
reduction of current by MeHg. This observation is consistent with
effects on whole cell Ca2+ currents previously
reported in PC12 cells (Shafer et al., 1990
), effects on synaptosomal
45Ca2+ influx (Shafer and
Atchison, 1989
), and effects at the neuromuscular junction (Traxinger
and Atchison, 1987
). It suggests that MeHg may compete with
Ba2+ for the same active sites within the channel
(steric overlap) or there may be a steric hindrance due to close
proximity of their binding sites.
The original aim of this study was to begin to reconcile differences in
action of MeHg between results of acute electrophysiological-type studies with those of functional studies in which antagonists of L-type
Ca2+ channels delay or protect against
MeHg-induced neurotoxicity. One possibility was that L-type channels
were not blocked by MeHg and perhaps even had current flow
enhanced by the metal. However, MeHg reduces amplitude of
currents carried through recombinant L-type channels, albeit not
completely. A second possibility was that short-term exposures to MeHg
impeded Ca2+ channel function, whereas longer
exposures might facilitate current flow. The present study did not
address this possibility directly; however, Shafer et al. (2002)
find that exposure of PC12 cells to micromolar concentrations of MeHg
for up to 24 h still impeded current flow. The most parsimonious
explanation for this dichotomy is that MeHg itself enters cells through
Ca2+ channels of various phenotypes
including
L-type. Such a phenomenon is reported to occur for other neurotoxic
metals such as Pb2+ (Simons and Pocock, 1987
) and
Cd2+ (Hinkle et al., 1987
, 1992
; Hinkle and
Osborne, 1994
) and is consistent with results from in situ preparations
in which KCl- or veratridine-induced depolarizations hastened the onset
of increased miniature end-plate potential frequency with MeHg, even in
the absence of extracellular Ca2+ (Atchison,
1986
, 1987
). Thus, the ability of L-type Ca2+
channel blockers to protect against actions of MeHg may then reflect
their ability to prevent its entry into the cell prior to producing
intracellular actions. The question, then, is, how does MeHg enter the
channel if the blocking action was neither voltage-dependent nor
use-dependent? Both of these factors should enhance entry of MeHg into
the channel.
In conclusion, MeHg alters function of heterologously expressed, recombinant human neuronal L-type Ca2+ channels at low micromolar concentrations, concentrations well within the range associated with MeHg neurotoxicity in vivo. The mechanism by which this occurs and the consequences of this action are not yet clear. However, this action is temporally among the earliest reported for MeHg and, thus, would be expected to contribute ultimately to the neurotoxic effects.
| |
Acknowledgments |
|---|
We thank SIBIA Neurosciences, now Merck Research Laboratories, for the generous contribution of the Ca2+ channel cDNA clones. We also thank Dr. Peter J. R. Cobbett for discussion and constructive criticisms throughout the work presented here.
| |
Footnotes |
|---|
Accepted for publication April 11, 2002.
Received for publication January 4, 2002.
Supported by National Institute of Environmental Health Sciences Grant ES03299. Preliminary results of this article were presented at the 30th Annual Meeting of the Society for Neuroscience in New Orleans, LA, and published in abstract form in Soc Neurosci Abstr 26:621, 2000.
DOI: 10.1124/jpet.102.032748
Address correspondence to: Dr. Bill Atchison, Department of Pharmacology and Toxicology, Michigan State University, B-331 Life Sciences Building, East Lansing, MI 48824-1317. E-mail: atchiso1{at}msu.edu
| |
Abbreviations |
|---|
MeHg, methylmercury;
HEK, human embryonic
kidney;
DHP, dihydropyridine;
Bay K8644, S-(
)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)-3
pyridine carboxylic acid methyl ester;
GFP, green fluorescent protein;
IBa, Ba2+ current;
PC12, pheochromocytoma;
[Ba2+]e, extracellular
barium concentration.
| |
References |
|---|
|
|
|---|
critical targets of toxicants and diseases.
Environ Health Perspect
108:
1215-1218.
1A subunit gene generates phenotypic variants of P- and Q-type calcium channels.
Nat Neurosci
2:
407-415[CrossRef][Medline].
1 and
subunits.
J Gen Physiol
105:
289-305
1,
2 and
subunits of a novel human neuronal calcium channel subtype.
Neuron
8:
71-84[CrossRef][Medline].
1E calcium channel subtypes.
J Biol Chem
269:
22347-22357This article has been cited by other articles:
![]() |
C. J. Herden, N. E. Pardo, R. K. Hajela, Y. Yuan, and W. D. Atchison Differential Effects of Methylmercury on {gamma}-Aminobutyric Acid Type A Receptor Currents in Rat Cerebellar Granule and Cerebral Cortical Neurons in Culture J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 517 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tarabova, M. Kurejova, Z. Sulova, M. Drabova, and L. Lacinova Inorganic Mercury and Methylmercury Inhibit the Cav3.1 Channel Expressed in Human Embryonic Kidney 293 Cells by Different Mechanisms J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 418 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Hajela, S.-Q. Peng, and W. D. Atchison Comparative Effects of Methylmercury and Hg2+ on Human Neuronal N- and R-Type High-Voltage Activated Calcium Channels Transiently Expressed in Human Embryonic Kidney 293 Cells J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yuan and W. D Atchison Methylmercury differentially affects GABAA receptor-mediated spontaneous IPSCs in Purkinje and granule cells of rat cerebellar slices J. Physiol., July 1, 2003; 550(1): 191 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Peng, R. K. Hajela, and W. D. Atchison Characteristics of Block by Pb2+ of Function of Human Neuronal L-, N-, and R-Type Ca2+ Channels Transiently Expressed in Human Embryonic Kidney 293 Cells Mol. Pharmacol., December 1, 2002; 62(6): 1418 - 1430. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||